Search results for "Riure"

showing 10 items of 200 documents

2015

Background and purpose Silent atrial fibrillation (AF) and tachycardia (AT) are considered precursors of ischaemic stroke. Therefore, detection of paroxysmal atrial rhythm disorders is highly relevant, but is clinically challenging. We aimed to evaluate the diagnostic value of natriuretic peptide levels in the detection of paroxysmal AT/AF in a pilot study. Methods Natriuretic peptide levels were analysed in two independent patient cohorts (162 patients with arterial hypertension or other cardiovascular risk factors and 82 patients with retinal vessel disease). N-terminal-pro-brain natriuretic peptide (NT-proBNP) and BNP were measured before the start of a 7-day Holter monitoring period car…

TachycardiaPediatricsmedicine.medical_specialtybusiness.industrymedicine.drug_classParoxysmal atrial fibrillationArea under the curveAtrial fibrillation030204 cardiovascular system & hematologymedicine.disease3. Good health03 medical and health sciences0302 clinical medicineInternal medicinemedicineCardiologyNatriuretic peptideIn patientSinus rhythmcardiovascular diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessStroke030217 neurology & neurosurgeryOpen Heart
researchProduct

Left Atrial Remodeling and Brain Natriuretic Peptide Levels Variation after Left Atrial Appendage Occlusion

2021

Background: Few data are available about brain natriuretic peptide (BNP) variation and left atrial remodeling after the left atrial appendage occlusion (LAAO) technique. Methods: Prospective study included all consecutive patients successfully implanted with an LAAO device. Contrast-enhanced cardiac computed tomography (CT) was performed before and 6 weeks after the procedure with reverse left atrial remodeling defined by an increase in LA volume &gt

atrial remodelingmedicine.medical_specialtyleft atrial appendage occlusionmedicine.medical_treatmentPopulation030204 cardiovascular system & hematologyLeft atrial appendage occlusionArticle03 medical and health scienceschemistry.chemical_compound0302 clinical medicinebleeding riskInternal medicinemedicineatrial fibrillation030212 general & internal medicinecardiovascular diseasesThrombuseducationeducation.field_of_studyCreatinineEjection fractionbusiness.industryRAtrial fibrillationGeneral Medicineatrial cardiopathyBrain natriuretic peptidemedicine.diseasechemistryCardiologycardiovascular systemMedicinebusinessBlood samplingBNPJournal of Clinical Medicine
researchProduct

Natriuretic peptide system: physiology and clinical utility

2004

This review discusses the physiology of natriuretic peptides as a group and brain natriuretic peptide (BNP) in more detail. It will also highlight implications for the use of the natriuretic peptides in the diagnosis and treatment of patients with cardiovascular disease.The heart secretes two major natriuretic peptides: atrial natriuretic peptide (ANP), which is synthesized in the atrial myocardium, and BNP, which is synthesized in the ventricular myocardium. Both ANP and BNP are released in response to atrial and ventricular stretch, respectively, and will cause balanced vasodilation, natriuresis, and inhibition of the sympathetic nervous system and the renin-angiotensin-aldosterone axis. …

business.industrymedicine.drug_classMolecular Sequence DataPhysiologyPrognosisCritical Care and Intensive Care MedicineBrain natriuretic peptideNPR2Cardiovascular DiseasesNatriuretic Peptide BrainNatriuretic peptideHumansMedicineAmino Acid SequenceNatriuretic PeptidesbusinessPeptide sequenceAtrial Natriuretic FactorBiomarkersCurrent Opinion in Critical Care
researchProduct

Role of biomarkers in monitoring antiblastic cardiotoxicity

2016

Early detection of anticancer drug-induced cardiotoxicity (CTX) has been evaluated by most international scientific cardiology and oncology societies. High expectations have been placed on the use of specific biomarkers. In recent years, conventional biomarkers and molecules of more recent interest have been tested and compared in the context of anticancer drug-related CTX. Encouraging results were obtained from studies on molecules of myocardial damage, such as troponin and markers of myocardial wall stress, including circulating natriuretic peptides, as well as from the assessment of the products of inflammation or circulating levels of free radicals. However, clear guidelines on their se…

cardiac toxicitymedicine.medical_specialtyantiblasticantineoplasticEarly detectionContext (language use)Antineoplastic Agentsantiblastic; anticancer drugs; antineoplastic; biomarkers; brain natriuretic peptide; cardiac toxicity; troponin; Cardiology and Cardiovascular Medicine030204 cardiovascular system & hematologyBioinformaticsbrain natriuretic peptideSensitivity and Specificity03 medical and health sciencesWall stress0302 clinical medicineCardiac toxicityNeoplasmsNatriuretic Peptide BrainmedicineHumansanticancer drugIntensive care medicineantineoplastic antiblastic anticancer drugs biomarkers brain natriuretic peptide cardiac toxicity troponinMonitoring PhysiologicCardiotoxicitybusiness.industrytroponinbiomarkersGeneral MedicineTime optimalCardiotoxicityanticancer drugsEarly DiagnosisCardiovascular Diseases030220 oncology & carcinogenesisbiomarkerbusinessCardiology and Cardiovascular Medicine
researchProduct

Teacher smiles as an interactional and pedagogical resource in the classroom

2020

In classroom settings, laughter and smiles are resources for action that are available to both teachers and students. Recent interactional studies have documented how students use these resources to deal with trouble of various kind, but less is known about the sequential and activity contexts of teachers’ laughter-relevant practices, as well as their pedagogical functions. We use multimodal conversation analysis (CA) to investigate the interactional unfolding and pedagogical orientations of teacher smiles during instructional IRE (initiation-response-evaluation) sequences in a corpus of 37 bilingual lessons collected in schools in Finland and Spain. In analysing the focal smiles, we pay at…

conversation analysisConversation analysisAprendizaje integrado de contenido e idiomas (CLIL)hymyAnálisis de conversacionesluokkatyöskentelySmileAnàlisi de conversesnaurucontent and language integrated learning (CLIL)opettaja-oppilassuhdeAprenentatge integrat de contingut i idiomes (CLIL)keskustelunanalyysismiling37SonrisaRiureopetustilanneLaughvieraskielinen opetusSomriureInteraction in the classroomInteracción en el aula risaclassroom interactionlaughterInteracció a l'aulaIntegrated content and language learning (CLIL)
researchProduct

Evaluación de nuevas estrategias diagnósticas en el síndrome de bajo gasto cardíaco postoperatorio

2020

Introducción. El síndrome de bajo gasto cardíaco (SBGC) es una complicación grave del postoperatorio en los pacientes sometidos a cirugía cardíaca que asocia una morbilidad y mortalidad significativas. El desarrollo de SBGC es multifactorial incluyendo factores preoperatorios, intraoperatorios y postoperatorios. El diagnóstico y el tratamiento precoz se consideran clave para mejorar los resultados clínicos. Dentro de las herramientas diagnósticas del SBGC y la monitorización de la respuesta al tratamiento inotropo disponemos entre otros de los biomarcadores plasmáticos y la ecocardiografía. La determinación preoperatoria y postoperatoria de los péptidos natriuréticos (PN) ha mostrado una im…

ecocardiografiadobutaminaUNESCO::CIENCIAS MÉDICASsindrome de bajo gasto cardiaco:CIENCIAS MÉDICAS [UNESCO]peptidos natriureticos
researchProduct

Protective Effects of a Discontinuous Treatment with Alpha-Lipoic Acid in Obesity-Related Heart Failure with Preserved Ejection Fraction, in Rats

2020

Obesity induces hemodynamic and humoral changes that are associated with functional and structural cardiac remodeling, which ultimately result in the development of heart failure (HF) with preserved ejection fraction (HFpEF). In recent years, pharmacological studies in patients with HFpEF were mostly unsatisfactory. In these conditions, alternative new therapeutic approaches are necessary. The aim of our study was (1) to assess the effects of obesity on heart function in an experimental model and (2) to evaluate the efficacy of an alpha-lipoic acid (ALA) antioxidant treatment. Sprague-Dawley rats (7 weeks old) were either included in the control group (n = 6) or subjected to abdominal aorti…

heart failure with preserved ejection fraction0301 basic medicineobesitymedicine.medical_specialtyPhysiologymedicine.drug_classClinical BiochemistryDiastoleHemodynamics030204 cardiovascular system & hematologymedicine.disease_causeBiochemistryArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicineNatriuretic peptideoxidative stressMolecular BiologyEjection fractionAdiponectinbusiness.industryalpha-lipoic acidlcsh:RM1-950Cell Biologymedicine.diseaselcsh:Therapeutics. Pharmacologyantioxidants030104 developmental biologyEndocrinologyHeart failurebusinessHeart failure with preserved ejection fractionOxidative stressAntioxidants
researchProduct

ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure

2017

Abstract Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or pharmacological responses to a therapeutic intervention. Natriuretic peptides [B-type natriuretic peptide (BNP) and N-terminal proBNP] are the gold standard biomarkers in determining the diagnosis and prognosis of HF, and a natriuretic peptide-guided HF management looks promising. In the last few years, an array of additional biomarkers has emerged, each reflecting different pathophysiological processes in the development and progression of HF: …

medicine.drug_classFibrosiGalectin 3Heart failure030204 cardiovascular system & hematologyBioinformatics03 medical and health sciences0302 clinical medicineFibrosismedicineNatriuretic peptideNatriuretic peptides030212 general & internal medicineBiomarkers; Fibrosis; Galectin 3; Heart failure; Inflammation; Natriuretic peptides; Troponin; Cardiology and Cardiovascular MedicinePathologicalInflammationbiologybusiness.industryArticlesBiomarkermedicine.diseaseBrain natriuretic peptideFibrosisTroponinTroponinGalectin-3Heart failurebiology.proteinBiomarker (medicine)businessCardiology and Cardiovascular MedicineBiomarkers; Fibrosis; Galectin 3; Heart failure; Inflammation; Natriuretic peptides; TroponinBiomarkersNatriuretic peptide
researchProduct

Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study

2021

AIMS: Although acute heart failure (AHF) with volume overload is treated with loop diuretics, their dosing and type of administration are mainly based upon expert opinion. A recent position paper from the Heart Failure Association (HFA) proposed a step-wise pharmacologic diuretic strategy to increase the diuretic response and to achieve rapid decongestion. However, no study has evaluated this protocol prospectively. METHODS AND RESULTS: The Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure (ENACT-HF) study is an international, multicentre, non-randomized, open-label, pragmatic study in AHF patients on chronic loop diuretic therapy, admitted to the hospital for intravenous …

medicine.drug_classmedicine.medical_treatmentStudy DesignsDecongestionVolume overloadDiuresisNatriuresisSodium Potassium Chloride Symporter InhibitorsFurosemideAcute heart failure; Diuretics; Urinary sodium; Decongestion; ProtocolmedicineClinical endpointProtocolHumansDiseases of the circulatory (Cardiovascular) systemInfusions IntravenousDiureticsHeart FailureUrinary sodiumStudy Designbusiness.industryFurosemideAcute heart failureLoop diureticmedicine.diseaseAnesthesiaHeart failureRC666-701DiureticCardiology and Cardiovascular Medicinebusinessmedicine.drugESC Heart Failure
researchProduct

Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure.

2021

Heart failure (HF) is a clinical syndrome that causes high morbidity and mortality with a high number of admissions and sometimes prolonged admissions. This study aimed at assessing whether parameters detected during the first 24 h of admission may predict a prolonged hospital stay in patients admitted to hospital for decompensated HF.From January 2016 to December 2019, 2359 admissions of decompensated HF were recorded. In-hospital transfers,Univariate differences were found at admission in NT-ProBNP, creatinine, history of cardiac surgery, smoking and alcoholism, left and right ventricular ejection fraction, systolic blood pressure and heart rate. The ROC analysis showed significant areas …

medicine.medical_specialty030204 cardiovascular system & hematology03 medical and health scienceschemistry.chemical_compoundHigh morbidity0302 clinical medicineNatriuretic Peptide BrainmedicineHumansDecompensation030212 general & internal medicineClinical syndromeHeart FailureCreatininebusiness.industryStroke VolumeGeneral MedicineLength of Staymedicine.diseasePeptide FragmentschemistryHeart failureCreatinineEmergency medicineVentricular Function RightCardiology and Cardiovascular MedicinebusinessHospital stayActa cardiologica
researchProduct